Gastrointestinal side effects demonstrated higher incidence compared to GLP-1 monotherapy (nausea 66% vs
While all three are given as once-weekly subcutaneous injections, the studied dose ranges differ considerably, reflecting differences in potency, receptor activity, and tolerability
Novel Peptide Discovery: Computational scans across the genome flag hundreds of uncharacterized precursors, facilitating new peptide discovery
Bechlioulis A, Markozannes G, Chionidi I, et al
Ongoing support from a clinical care team: Stay connected with a dedicated team that monitors your progress, answers questions, adjusts your treatment as needed, and helps you manage side effects or plateaus
Nicole W